Literature DB >> 29689727

Vascular Cognitive Impairment and the Gut Microbiota.

Sinian Li1, Yiming Shao2, Kanglan Li1, Changmei HuangFu3, Wenjie Wang4, Zhou Liu1, Zhiyou Cai5, Bin Zhao1.   

Abstract

Vascular cognitive impairment (VCI), the second most common cause of dementia in elderly people, is a term that refers to all forms of cognitive disorders that can be attributed to cerebrovascular disease such as manifestations of discrete infarctions, brain hemorrhages, and white matter lesions. The gut microbiota (GM) has emerged recently as an essential player in the development of VCI. The GM may affect the brain's physiological, behavioral, and cognitive functions through the brain-gut axis via neural, immune, endocrine, and metabolic pathways. Therefore, microbiota dysbiosis may mediate or affect atherosclerosis, cerebrovascular disease, and endothelial dysfunction, which are the predominant risk factors for VCI. Moreover, the composition of the GM includes the bacterial component lipopolysaccharides and their metabolic products including trimethylamine-N-oxide and short-chain fatty acids. These products may increase the permeability of the intestinal epithelium, leading to systemic immune responses, low-grade inflammation, and altered signaling pathways that are associated with the pathogenesis of VCI. In this review, we discuss the proposed mechanisms of the GM in the maintenance of VCI and how it is implicated in acquired metabolic diseases, particularly in VCI regulation.

Entities:  

Keywords:  Atherosclerosis; cerebrovascular disease; endothelial dysfunction; gut microbiota; lipopolysaccharides; short-chain fatty acids; trimethylamine-N-oxide; vascular cognitive impairment

Mesh:

Year:  2018        PMID: 29689727     DOI: 10.3233/JAD-171103

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  9 in total

1.  Effect and Mechanism of Yisui Fuyongtang (YSFYT) Decoction on Cognitive Function and Synaptic Plasticity in Rats with Vascular Cognitive Impairment.

Authors:  Tingliang Gong; Zhaoliang Luo; Li Huang; Caixian Xiao; Junlu Yi; Junfeng Yan; Qian Chen; Weihong Li; Wenqiang Tao
Journal:  J Immunol Res       Date:  2022-07-08       Impact factor: 4.493

Review 2.  The influence of gut microbiota alteration on age-related neuroinflammation and cognitive decline.

Authors:  Amsha S Alsegiani; Zahoor A Shah
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

Review 3.  Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review.

Authors:  Andrea Ticinesi; Claudio Tana; Antonio Nouvenne; Beatrice Prati; Fulvio Lauretani; Tiziana Meschi
Journal:  Clin Interv Aging       Date:  2018-08-29       Impact factor: 4.458

4.  Is Qi Fu Yin effective in clinical treatment of dementia?: A meta-analysis of 697 patients.

Authors:  Lei Wang; Pengli Qiao; Lulu Yue; Rong Sun
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

5.  Magnetic Resonance Image Feature Analysis under Deep Learning in Diagnosis of Neurological Rehabilitation in Patients with Cerebrovascular Diseases.

Authors:  Xue Li; Wenjun Ji; Hufei Chang; Chunyan Yang; Zhao Rong; Jun Hao
Journal:  Contrast Media Mol Imaging       Date:  2021-10-25       Impact factor: 3.161

Review 6.  Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Cell Biosci       Date:  2022-06-28       Impact factor: 9.584

7.  Analysis of risk factors for the development of cognitive dysfunction in patients with cerebral small vessel disease and the construction of a predictive model.

Authors:  Le Zhang; Fulin Gao; Yamin Zhang; Pengjuan Hu; Yuping Yao; Qingzhen Zhang; Yan He; Qianlan Shang; Yi Zhang
Journal:  Front Neurol       Date:  2022-08-11       Impact factor: 4.086

Review 8.  Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia.

Authors:  Emily Connell; Gwenaelle Le Gall; Matthew G Pontifex; Saber Sami; John F Cryan; Gerard Clarke; Michael Müller; David Vauzour
Journal:  Mol Neurodegener       Date:  2022-06-17       Impact factor: 18.879

Review 9.  Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia.

Authors:  Tuo Yang; Feng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.